(CSE: SURE) (OTCQB: SURNF), (Profile) through its subsidiary GlucaPharm Inc., is advancing a differentiated next-generation GLP-1 platform centered on GEP-44, a novel triple agonist peptide designed to improve efficacy, tolerability and delivery flexibility in one of the fastest-growing pharmaceutical markets in history
A standout is tirzepatide, a GLP1 medication and dual GIPGLP1 receptor agonist, marketed as Mounjaro for diabetes and used off-label for weight loss
Three clinical trials are ongoing to investigate MIJ821 receptor occupancy in the brain (NCT05666687) and safety and efficacy in people with TRD (NCT05454410) or MDD with suicidal ideation with intent (NCT04722666)
As a result, the hair follicles remain weakened, which limits the therapeutic benefits of PRP therapy (if any)
IGF-1 Signaling, Tissue Repair, and Recovery Models The CJC-1295 No DAC with Ipamorelin blend finds further research application in tissue remodeling and recovery biology mediated through downstream IGF-1 signaling
The 24-year-old said she finally buckled under a range of stresses at the July event including the unresolved trauma of having been sexually abused by former USA Gymnastics doctor Larry Nassar
